Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Journal: Journal of the American Heart Association
Published: March 04, 2020
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.
Journal: The American journal of cardiology
Published: April 22, 2018
Administration of Rotaglide™ solution for treating refractory severe radial artery spasm: A case report.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 14, 2018
Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.
Journal: Journal of cardiovascular pharmacology
Published: April 11, 2018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.
Journal: Diabetes, obesity & metabolism
Published: February 18, 2018
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Journal: Circulation. Heart failure
Published: June 29, 2017
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
Journal: Journal of cardiovascular pharmacology
Published: February 25, 2016
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.
Journal: The American journal of cardiology
Published: September 07, 2015
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies).
Journal: The American journal of cardiology
Published: October 04, 2014
Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).
Journal: The American journal of cardiology
Published: August 17, 2014
Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra.
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 17, 2014
Clinical predictors of response to anakinra in patients with heart failure.
Journal: International journal of cardiology
Published: January 04, 2014
Last Updated: 09/26/2026